Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
$0Marie Fidela R. Paraiso, MD, is a Staff Physician in the Department of Obstetrics and Gynecology at Cleveland Clinic, where she also serves as Head of the Center for Urogynecology and Reconstructive Pelvic Surgery. Additionally, Dr. Paraiso holds a joint appointment in the Cleveland Clinic Urological Institute. She specializes in the treatment of urinary and fecal incontinence and pelvic organ prolapse. She also is Director of the Pelvic Floor Disorders Center at Lakewood Hospital.$0$0Dr. Paraiso is board-certified in obstetrics and gynecology, and her expertise includes laparoscopic and robotic-assisted laparoscopic surgery, incontinence, pelvic organ prolapse, vaginal surgery and neuromodulation. She is a frequent invited lecturer for local, national and international scientific meetings and has been published in numerous professional publications, including Obstetrics and Gynecology
, American Journal of Obstetrics and Gynecology
, Minimally Invasive Gynecology
, International Urogynecology Journal
, OB/GYN Management
, European Journal of Gynecologic Oncology
, and Review Journal of the Netherlands
.$0$0She received her degree from the Indiana University School of Medicine in Indianapolis. She completed her residency in obstetrics and gynecology, as well as research fellowships in advanced pelvic surgery and advanced endoscopic surgery and urogynecology at Cleveland Clinic.$0$0Dr. Paraiso's professional memberships include the International Urogynecologic Association, the International Continence Society, the American College of Obstetrics and Gynecology, the American Association of Gynecologic Laparoscopy, the Society of Gynecologic Surgeons, the American Urogynecologic Society and the Society of Laparoendoscopic Surgeons. She is presently on the Board of Directors of the American Urogynecologic Society and National Advisory Board for the American Association of Gynecologic Laparoscopists.$0$0Watch a video about Dr. Paraiso.
Recent postgraduate course for the the International Urogynecology Association in Lake Como, Italy lecturing on robotic and conventional laparoscopy for pelvic organ prolapse
Bowel dysfunction and fecal incontinence, complex vaginal surgery, hysterectomy, incontinence (minimally invasive and office procedures), laparoscopic and robotic female prolapse and reconstructive surgery, myomectomy and endometriosis, sexual dysfunction vaginal reconstruction, urogynecology and pelvic reconstructive surgery, voiding dysfunction and neuromodulation
Awards & Honors
$0$0Best Doctors in America, 2006, 2007, 2008, 2009$0$0Best Doctors, Cleveland Magazine 2006, 2007, 2008, 2009$0$0Editorial Advisory Board for the Journal of Minimally Invasive Gynecology$0$0American Association of Gynecologic Laparoscopists National Advisory Board$0$0American Urogynecologic Society Board of Directors, Member-at-Large$0$0Alternate Primary Investigator for the Pelvic Floor Disorders Network$0$0Top 100 Reviewers for the American Journal of Obstetrics and Gynecology$0$0
Innovations & Patents
$0Advanced Laparoscopy, Robotic surgery, midurethral slings, mini-slings, advanced vaginal reconstructive surgery, Pelvic organ prolapse repair kit procedures, sacral neuromodulation (bladder pacemakers)$0
$0$0American Urogynecologic Society $0$0American Association of Gynecologic Laparoscopists$0$0Fellow, American College of Obstetricians & Gynecologists$0$0Society of Gynecologic Surgeons$0$0International Continence Society$0$0International Urogynecologic Association$0$0
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 3/18/2015, Dr. Paraiso has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.